Literature DB >> 24387662

Nuclease-mediated genome editing: At the front-line of functional genomics technology.

Tetsushi Sakuma1, Knut Woltjen.   

Abstract

Genome editing with engineered endonucleases is rapidly becoming a staple method in developmental biology studies. Engineered nucleases permit random or designed genomic modification at precise loci through the stimulation of endogenous double-strand break repair. Homology-directed repair following targeted DNA damage is mediated by co-introduction of a custom repair template, allowing the derivation of knock-out and knock-in alleles in animal models previously refractory to classic gene targeting procedures. Currently there are three main types of customizable site-specific nucleases delineated by the source mechanism of DNA binding that guides nuclease activity to a genomic target: zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR). Among these genome engineering tools, characteristics such as the ease of design and construction, mechanism of inducing DNA damage, and DNA sequence specificity all differ, making their application complementary. By understanding the advantages and disadvantages of each method, one may make the best choice for their particular purpose.
© 2014 The Authors Development, Growth & Differentiation © 2014 Japanese Society of Developmental Biologists.

Keywords:  clustered regularly interspaced short palindromic repeats; genome editing; transcription activator-like effector nucleases; zinc-finger nucleases

Mesh:

Substances:

Year:  2014        PMID: 24387662     DOI: 10.1111/dgd.12111

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  22 in total

1.  Homeolog-specific targeted mutagenesis in Xenopus laevis using TALENs.

Authors:  Shota Nakade; Tetsushi Sakuma; Yuto Sakane; Yoshihiro Hara; Atsushi Kurabayashi; Keiko Kashiwagi; Akihiko Kashiwagi; Takashi Yamamoto; Masanobu Obara
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-29       Impact factor: 2.416

2.  A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping.

Authors:  Takenori Shimo; Kana Hosoki; Yusuke Nakatsuji; Toshifumi Yokota; Satoshi Obika
Journal:  J Hum Genet       Date:  2018-01-16       Impact factor: 3.172

3.  MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.

Authors:  Tetsushi Sakuma; Shota Nakade; Yuto Sakane; Ken-Ichi T Suzuki; Takashi Yamamoto
Journal:  Nat Protoc       Date:  2015-12-17       Impact factor: 13.491

Review 4.  Gene therapy for cancer: present status and future perspective.

Authors:  Magid H Amer
Journal:  Mol Cell Ther       Date:  2014-09-10

5.  Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system.

Authors:  Tetsushi Sakuma; Ayami Nishikawa; Satoshi Kume; Kazuaki Chayama; Takashi Yamamoto
Journal:  Sci Rep       Date:  2014-06-23       Impact factor: 4.379

Review 6.  Advances in genome editing technology and its promising application in evolutionary and ecological studies.

Authors:  Lei Chen; Linyi Tang; Hui Xiang; Lijun Jin; Qiye Li; Yang Dong; Wen Wang; Guojie Zhang
Journal:  Gigascience       Date:  2014-10-30       Impact factor: 6.524

7.  Simple knockout by electroporation of engineered endonucleases into intact rat embryos.

Authors:  Takehito Kaneko; Tetsushi Sakuma; Takashi Yamamoto; Tomoji Mashimo
Journal:  Sci Rep       Date:  2014-10-01       Impact factor: 4.379

8.  Germline-transmitted genome editing in Arabidopsis thaliana Using TAL-effector-nucleases.

Authors:  Joachim Forner; Anne Pfeiffer; Tobias Langenecker; Pablo A Manavella; Pablo Manavella; Jan U Lohmann
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens.

Authors:  Fabian Schmich; Ewa Szczurek; Saskia Kreibich; Sabrina Dilling; Daniel Andritschke; Alain Casanova; Shyan Huey Low; Simone Eicher; Simone Muntwiler; Mario Emmenlauer; Pauli Rämö; Raquel Conde-Alvarez; Christian von Mering; Wolf-Dietrich Hardt; Christoph Dehio; Niko Beerenwinkel
Journal:  Genome Biol       Date:  2015-10-07       Impact factor: 13.583

10.  CRISPR/Cas9-mediated gene knockout in the ascidian Ciona intestinalis.

Authors:  Haruka Sasaki; Keita Yoshida; Akiko Hozumi; Yasunori Sasakura
Journal:  Dev Growth Differ       Date:  2014-09-12       Impact factor: 2.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.